202 related articles for article (PubMed ID: 10446061)
1. Oncostatin M induces angiogenesis in vitro and in vivo.
Vasse M; Pourtau J; Trochon V; Muraine M; Vannier JP; Lu H; Soria J; Soria C
Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1835-42. PubMed ID: 10446061
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro.
Pepper MS; Ferrara N; Orci L; Montesano R
J Cell Sci; 1995 Jan; 108 ( Pt 1)():73-83. PubMed ID: 7537748
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes.
Weiss TW; Speidl WS; Kaun C; Rega G; Springer C; Macfelda K; Losert UM; Grant SL; Marro ML; Rhodes AD; Fuernkranz A; Bialy J; Ullrich R; Holzmann P; Pacher R; Maurer G; Huber K; Wojta J
Cardiovasc Res; 2003 Sep; 59(3):628-38. PubMed ID: 14499864
[TBL] [Abstract][Full Text] [Related]
4. Leukaemia inhibitory factor and oncostatin M modulate expression of urokinase plasminogen activator and fibrinogen.
Okada H; Woodcock-Mitchell J; Fujii S
Coron Artery Dis; 1996 Aug; 7(8):561-7. PubMed ID: 8922882
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 activity is necessary for the angiogenic properties of oncostatin M.
Pourtau J; Mirshahi F; Li H; Muraine M; Vincent L; Tedgui A; Vannier JP; Soria J; Vasse M; Soria C
FEBS Lett; 1999 Oct; 459(3):453-7. PubMed ID: 10526183
[TBL] [Abstract][Full Text] [Related]
6. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
8. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.
Koolwijk P; van Erck MG; de Vree WJ; Vermeer MA; Weich HA; Hanemaaijer R; van Hinsbergh VW
J Cell Biol; 1996 Mar; 132(6):1177-88. PubMed ID: 8601593
[TBL] [Abstract][Full Text] [Related]
9. SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.
Mirshahi F; Pourtau J; Li H; Muraine M; Trochon V; Legrand E; Vannier J; Soria J; Vasse M; Soria C
Thromb Res; 2000 Sep; 99(6):587-94. PubMed ID: 10974345
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelial cell growth by macrophage-like U-937 cell-derived oncostatin M, leukemia inhibitory factor, and transforming growth factor beta1.
Takashima S; Klagsbrun M
J Biol Chem; 1996 Oct; 271(40):24901-6. PubMed ID: 8798767
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor.
Mirshahi F; Vasse M; Tedgui A; Li H; Merval R; Legrand E; Vannier JP; Soria J; Soria C
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):449-55. PubMed ID: 12138373
[TBL] [Abstract][Full Text] [Related]
13. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.
van Hinsbergh VW; Koolwijk P; Hanemaaijer R
EXS; 1997; 79():391-411. PubMed ID: 9002228
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
Mandriota SJ; Pepper MS
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.
Hartner A; Goppelt-Struebe M; Hocke GM; Sterzel RB
Kidney Int; 1997 Jun; 51(6):1754-60. PubMed ID: 9186863
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
19. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor enhances bFGF-induced IL-6 synthesis in osteoblasts: involvement of JAK2/STAT3.
Kozawa O; Otsuka T; Uematsu T
Cell Signal; 2002 Apr; 14(4):311-5. PubMed ID: 11858938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
